Krystal Biotech, Inc. (KRYS)

Revenue

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023
Product Revenue, Net	417.30M	389.13M	290.52M
Product Revenue, Net Growth	7.24%	33.95%	473.02%
Revenue (Total)	417.30M	389.13M	290.52M
Revenue (Total) Growth	7.24%	33.95%	473.02%

Data Source: Fiscal.ai Last updated: May 4, 2026

Financial data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 18, 2026

Data Sources Report a data error